Attention deficit/hyperactivity disorder: pharmacotherapy. - Wikidata - awgldk - TriplyDB

Attention deficit/hyperactivity disorder: pharmacotherapy.

Attention deficit/hyperactivity disorder: pharmacotherapy.

http://www.wikidata.org/entity/Q34418634

about

Amfetamine and methylphenidate medications for attention-deficit/hyperactivity disorder: complementary treatment options Efficacy of lisdexamfetamine dimesylate throughout the day in children and adolescents with attention-deficit/hyperactivity disorder: results from a randomized, controlled trial.

P2860

Q34286130-207919F7-E4D6-4799-801E-453B5D8644F1 Q37568899-4CF5B319-B0F7-4A0C-BA23-A10FE360C84E

P2860

Attention deficit/hyperactivity disorder: pharmacotherapy.

http://www.wikidata.org/entity/Q34418634

description

2005 nî lūn-bûn

@nan

2005 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Attention deficit/hyperactivity disorder: pharmacotherapy.

@ast

Attention deficit/hyperactivity disorder: pharmacotherapy.

@en

Attention deficit/hyperactivity disorder: pharmacotherapy.

@nl

type

label

Attention deficit/hyperactivity disorder: pharmacotherapy.

@ast

Attention deficit/hyperactivity disorder: pharmacotherapy.

@en

Attention deficit/hyperactivity disorder: pharmacotherapy.

@nl

prefLabel

Attention deficit/hyperactivity disorder: pharmacotherapy.

@ast

Attention deficit/hyperactivity disorder: pharmacotherapy.

@en

Attention deficit/hyperactivity disorder: pharmacotherapy.

@nl

P1433

Q34418634-750D36F2-323D-4B86-BC2C-23486EDC198A

P1476

Q34418634-3253551D-D575-43DB-B961-0083EA1225A1

P2093

Q34418634-FB12F26B-D562-4154-9429-77CF1AB044EB

P2860

Q34418634-1AA2A16E-C95B-4593-95A6-BE37D667E722

Q34418634-249A5FBA-2DA4-47D6-A727-658EF0802386

Q34418634-2E1937C0-57C6-49A7-8401-A528AE624A38

Q34418634-2F7DA9EA-6D47-4B87-92D4-1EB76AF6C5FB

Q34418634-36FE3CE4-22C5-45E8-BAF0-3B7724F0E8CA

Q34418634-3A7035D8-0999-4695-8DBB-D3E836036CC9

Q34418634-488932E9-A614-4063-8851-BCA705BF3D48

Q34418634-49951810-4F82-4FC1-8B1D-09D32B230570

Q34418634-49CFCBFA-85C3-4436-AEB2-CB4EE5212735

Q34418634-4ABA74C1-EDE1-4B18-97E5-2A4B9720C0EF

P304

Q34418634-430D0E38-8EC0-40E1-8954-0C4011531AD6

P31

Q34418634-4B890184-FDCC-4E06-B58B-1759F0E36C3F

Q34418634-4af2b3cf-10c2-4669-a4d3-51cac32d9dee

P433

Q34418634-CED96940-6B44-46EF-B011-BBFF8D7C4080

P478

Q34418634-4A4F8042-9751-4293-8291-C33434A64970

P577

Q34418634-EE26C81B-6D83-4664-8B1B-A20F918D053F

P698

Q34418634-F48B68F2-01EB-45D5-8ECB-62BB8703F696

P921

Q34418634-4E2D068D-A2E1-45CA-82B8-0A49D60D8709

Q34418634-74F8FA3D-551D-473B-B2A6-A8CEF82B0BC1

P932

Q34418634-14380EB3-BEC4-4BA3-98DB-2D1FF4054013

P1433

P1476

Attention deficit/hyperactivity disorder: pharmacotherapy.

@en

P2093

Josephine Elia

http://www.w3.org/2001/XMLSchema#string

P2860

Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter

Efficacy of two once-daily methylphenidate formulations compared across dose levels at different times of the day: preliminary indications from a secondary analysis of the COMACS study data

Effect of food on early drug exposure from extended-release stimulants: results from the Concerta, Adderall XR Food Evaluation (CAFE) Study

Development of a new once-a-day formulation of methylphenidate for the treatment of attention-deficit/hyperactivity disorder: proof-of-concept and proof-of-product studies

Amphetamine redistributes dopamine from synaptic vesicles to the cytosol and promotes reverse transport

A pilot study of methylphenidate, clonidine, or the combination in ADHD comorbid with aggressive oppositional defiant or conduct disorder

Mice lacking dopamine D4 receptors are supersensitive to ethanol, cocaine, and methamphetamine

Impact of methylphenidate delivery profiles on driving performance of adolescents with attention-deficit/hyperactivity disorder: a pilot study.

A controlled clinical trial of bupropion for attention deficit hyperactivity disorder in adults.

A double-blind, placebo-controlled trial of dexmethylphenidate hydrochloride and d,l-threo-methylphenidate hydrochloride in children with attention-deficit/hyperactivity disorder.

P304

27-35

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

2005-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21179640

http://www.w3.org/2001/XMLSchema#string

P921

pharmacotherapy

P932

3004727

http://www.w3.org/2001/XMLSchema#string